Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MS
- Citation:
- J Pharm Biomed Anal vol 138 197-205
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 6
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- GU
- Pharmas:
- Grants:
- P30-CA47904, U10CA180821, CA31946, U10CA004326, U10CA007968, U10CA077651, U10CA180791, U10CA180844, U10CA180854, R50 CA211241, U10 CA007968, P30 CA047904, U10 CA031946, U10 CA180854, U10 CA180821, P30 CA023108, P30 CA008748, U10 CA180791, U10 CA077651, U10 CA180844
- Corr. Author:
- Authors:
- Kyu-pyo Kim Robert A. Parise Julianne L. Holleran Lionel D. Lewis Leonard Appleman Nielka van Erp Michael J. Morris Jan H. Beumer
- Networks:
- LAPS-MD017, LAPS-NH012, LAPS-NY016, LAPS-PA015
- Study
- Alliance-A031201
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- bicalutamide, enzalutamide, abiraterone, tandem mass spectrometry, metabolites, assay, validation